Reading Time: 2 minutesIn-depth coverage on Business, Tech, Lifestyle (and more) Â Be sure to check out PriceofBusiness.com for the latest updates. Â Read Instead Highlights (Read more & Subscribe here): Â Tariff Increases on Cars, Tariff Cuts on Scotch Announced, but the Read more…
Reading Time: 3 minutesIn-depth coverage on Business, Tech, Lifestyle (and more)Â Be sure to check out PriceofBusiness.com for the latest updates. Read Instead Highlights (Read more & Subscribe here): Crisis Management in the Digital Age: For Better or Worse, Social Media Frames the Read more…
Reading Time: 4 minutesRecently, AstraZeneca announced it would invest $50 billion in drug research and manufacturing over the next five years. At first glance, that sounds like great news—more innovation, better treatment options, and improved access to healthcare. But let’s ask the deeper Read more…
Reading Time: 4 minutesOver the past few years, a new class of drugs has gained enormous attention: GLP-1 receptor agonists, commonly known by brand names like Ozempic, Wegovy, and Mounjaro. Originally designed to help people manage Type 2 diabetes, these medications are now Read more…
